Korean J Med.
2016 Apr;90(4):330-333. 10.3904/kjm.2016.90.4.330.
Heart Failure Secondary to Pazopanib for Treatment of Metastatic Renal Cell Carcinoma
- Affiliations
-
- 1Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, Korea. ashneph@wonkwang.ac.kr
- KMID: 2268847
- DOI: http://doi.org/10.3904/kjm.2016.90.4.330
Abstract
- A 78-year-old man was diagnosed with renal cell carcinoma, and left nephrectomy was performed. He started pazopanib. One month later, he visited our hospital because of general weakness and dyspnea. His oxygen saturation was low. A chest X-ray showed pulmonary edema and bilateral pleural effusion. An echocardiogram showed a larger left ventricle and lower ejection fraction than observed at the previous examination. The patient discontinued pazopanib and started diuretics and digoxin. His symptoms improved and a follow-up X-ray showed improvement in the pulmonary edema with bilateral pleural effusion.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Pazopanib-induced Hair Depigmentation, Ulcerative Patch in a Patient with Metastatic Renal Cell Carcinoma
- Pazopanib for Non-small Cell Lung Cancer: The First Case Report in Korea
- Trends of First-Line Targeted Therapy in Korean Patients With Metastatic Clear Cell Renal Cell Carcinoma: Sunitinib Versus Pazopanib, a Multicenter Study
- A Case of Metastatic Renal Cell Carcinoma to the Gallbladder
- Spontaneous Regression of Pulmonary and Adrenal Metastases Following Percutaneous Radiofrequency Ablation of a Recurrent Renal Cell Carcinoma
